Beacon Pointe Advisors, LLC Abb Vie Inc. Transaction History
Beacon Pointe Advisors, LLC
- $8.89 Billion
- Q4 2024
A detailed history of Beacon Pointe Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 123,586 shares of ABBV stock, worth $26.8 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
123,586
Previous 130,743
5.47%
Holding current value
$26.8 Million
Previous $25.8 Million
14.94%
% of portfolio
0.25%
Previous 0.3%
Shares
25 transactions
Others Institutions Holding ABBV
# of Institutions
4,105Shares Held
1.28BCall Options Held
16.7MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA173MShares$37.5 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$29.6 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.6MShares$17.3 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY51.8MShares$11.2 Billion0.75% of portfolio
-
Morgan Stanley New York, NY39.7MShares$8.6 Billion0.51% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $383B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...